Medical doctors will find in this section abstracts about medical studies. Such they have been published by www.interscience. wiley .com . The full texts of these works in english language can be asked yoy leaving its data in "Contact for Physicians", being able also to carry out any consultation you want.

Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis.

DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone.

A New clinical score for disease activity in Langerhans cell histiocytosis.

Outcome in children with pulmonary Langerhans cell histiocytosis.

Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.

Retinoic acid therapy in "degenerative-like " neuro-langerhans cell histiocytosis: A prospective pilot study.

Pineal gland abnormalities in Langerhans cell histiocytosis.

Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.

Mondini dysplasia and recurrent bacterial meningitis in a girl with relapsing Langerhans cell histiocytosis.

Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society - Late Effects Study Group.